Found: 11
Select item for more details and to access through your institution.
Emerging Pharmacotherapy to Reduce Elevated Lipoprotein(a) Plasma Levels.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 255, doi. 10.1007/s40256-020-00437-7
- By:
- Publication type:
- Article
Effect of Sacubitril/Valsartan on Neurocognitive Function: Current Status and Future Directions.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 267, doi. 10.1007/s40256-020-00445-7
- By:
- Publication type:
- Article
Clinical Impact of Weight-Loss Pharmacotherapy in Patients with Atherosclerotic Cardiovascular Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 271, doi. 10.1007/s40256-020-00428-8
- By:
- Publication type:
- Article
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 283, doi. 10.1007/s40256-020-00434-w
- By:
- Publication type:
- Article
Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 299, doi. 10.1007/s40256-020-00435-9
- By:
- Publication type:
- Article
Effects of Dapagliflozin on Cardiovascular Events, Death, and Safety Outcomes in Patients with Heart Failure: A Meta-Analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 321, doi. 10.1007/s40256-020-00441-x
- By:
- Publication type:
- Article
Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 331, doi. 10.1007/s40256-020-00453-7
- By:
- Publication type:
- Article
The Restricted Mean Survival Time as a Tool for Ranking Comparative Outcomes in a Narrative Review that Evaluates a Network of Randomized Trials: An Example Based on PCSK9 Inhibitors.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 349, doi. 10.1007/s40256-020-00444-8
- By:
- Publication type:
- Article
Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 355, doi. 10.1007/s40256-020-00442-w
- By:
- Publication type:
- Article
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 363, doi. 10.1007/s40256-020-00449-3
- By:
- Publication type:
- Article
Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 373, doi. 10.1007/s40256-021-00466-w
- By:
- Publication type:
- Article